Red X iconGreen tick iconYellow tick icon

Mei Zhang

Research Associate Professor



Associate Professor Mei Zhang is a Research Associate Professor employed by Clinical Pharmacology, Department of Medicine, University of Otago, Christchurch and by Toxicology, Canterbury Health Laboratories.

Originally trained as a medical doctor in China, Mei has completed a PhD from the School of Pharmacy, University of Otago entitled Chiral Studies of the metabolism of formoterol and salmeterol in humans.

Mei develops assays for drug analysis from biological matrices that are being investigated in various departmental research projects and is continuing research in drug isomerisation.


Zhang, M., Moore, G., Chin, P. K. L., & Doogue, M. (2023). An efficient HILIC-MS/MS method for monitoring metformin in human plasma. Proceedings of the Australasian Society of Clinical & Experimental Pharmacologists & Toxicologists (ASCEPT) Annual Scientific Meeting: Transformational Pharmacology & Toxicology. P510. Retrieved from

Spangehl, M. J., Clarke, H. D., Moore, G. A., Zhang, M., Probst, N. E., & Young, S. W. (2022). Higher tissue concentrations of Vancomycin achieved with low dose intraosseous injection versus intravenous despite limited tourniquet duration in primary TKA: A randomized trial. Journal of Arthroplasty, 37, 857-863. doi: 10.1016/j.arth.2022.01.057

Everts, R. J., Gardiner, S. J., Zhang, M., Begg, R., Chambers, S. T., Turnidge, J., & Begg, E. J. (2021). Probenecid effects on cephalexin pharmacokinetics and pharmacodynamics in healthy volunteers. Journal of Infection, 83, 182-189. doi: 10.1016/j.jinf.2021.05.037

Drennan, P. G., Green, J. K., Gardiner, S. J., Metcalf, S. C. L., Kirkpatrick, C. M. J., Everts, R. J., Zhang, M., & Chambers, S. T. (2021). Population pharmacokinetics of free flucloxacillin in patients treated with oral flucloxacillin plus probenecid. British Journal of Clinical Pharmacology, 87, 4684-4693. doi: 10.1111/bcp.14887

McNeill, R. P., Zhang, M., Epton, M. J., & Doogue, M. P. (2021). Drub metabolism in severe chronic obstructive pulmonary disease: A phenotyping cocktail study. British Journal of Clinical Pharmacology, 87, 4397-4407. doi: 10.1111/bcp.14862

Back to top